Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-26T05:58:25.691Z Has data issue: false hasContentIssue false

Chapter 13 - Hypertension and Vascular Diseases of the Kidney

Published online by Cambridge University Press:  01 March 2017

By
Kuang-Yu Jen  and
Jean Olson
Edited by
Xin Jin (Joseph) Zhou ,
Zoltan G. Laszik ,
Tibor Nadasdy  and
Vivette D. D'Agati
Xin Jin (Joseph) Zhou
Affiliation:
Baylor University Medical Center, Dallas
Zoltan G. Laszik
Affiliation:
University of California, San Francisco
Tibor Nadasdy
Affiliation:
Ohio State University
Vivette D. D'Agati
Affiliation:
Columbia University, New York
Get access
Type
Chapter
Information
Silva's Diagnostic Renal Pathology , pp. 487 - 520
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bromfield, S, Muntner, P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013; 15:134–6.Google Scholar
Chobanian, AV, Bakris, GL, Black, HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206–52.Google Scholar
James, PA, Oparil, S, Carter, BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311:507–20.Google Scholar
Anderson, GH Jr., Blakeman, N, Streeten, DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994; 12:609–15.CrossRefGoogle ScholarPubMed
Omura, M, Yamaguchi, K, Kakuta, Y, Nishikawa, T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004; 27:193–202.Google Scholar
Egan, BM, Li, J, Hutchison, FN, Ferdinand, KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014; 130:1692–9.Google Scholar
Flynn, JT. Pediatric hypertension update. Curr Opin Nephrol Hypertens. 2010; 19:292–7.Google Scholar
Basson, J, Simino, J, Rao, DC. Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Curr Hypertens Rep. 2012; 14:46–61.CrossRefGoogle ScholarPubMed
Ehret, GB, Munroe, PB, Rice, KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011; 478:103–9.Google Scholar
Levy, D, Ehret, GB, Rice, K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009; 41:677–87.Google Scholar
Lu, X, Wang, L, Lin, X, et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum Molec Genet. 2015; 24:865–74.CrossRefGoogle ScholarPubMed
Millis, RM. Epigenetics and hypertension. Curr Hypertens Rep. 2011; 13:21–8.Google Scholar
Ritz, E, Amann, K, Koleganova, N, Benz, K. Prenatal programming – effects on blood pressure and renal function. Nat Rev Nephrol. 2011; 7:137–44.Google Scholar
Cutler, JA, Sorlie, PD, Wolz, M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008; 52:818–27.Google Scholar
Tu, W, Pratt, JH. A consideration of genetic mechanisms behind the development of hypertension in blacks. Curr Hypertens Rep. 2013; 15:108–13.Google Scholar
Tzur, S, Rosset, S, Shemer, R, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010; 128:345–50.Google Scholar
Hoy, WE, Hughson, MD, Kopp, JB, et al. APOL1 risk alleles are associated with exaggerated age-related changes in glomerular number and volume in African-American adults: an autopsy study. J Am Soc Nephrol. 2015; 26:3179–89.Google Scholar
Park, JB, Kario, K, Wang, JG. Systolic hypertension: an increasing clinical challenge in Asia. Hypertens Res. 2015; 38:227–36.Google Scholar
Krakoff, LR. Diagnosis: initial evaluation and follow-up assessment. In: Oparil, S, Weber, MA, editors. Hypertension. Philadelphia: Elsevier-Saunders; 2005: 295–304.Google Scholar
Cerasola, G, Cottone, S, Mule, G. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor. J Hypertens. 2010; 28:2357–69.Google Scholar
Lane, DA, Lip, GY, Beevers, DG. Improving survival of malignant hypertension patients over 40 years. Am J Hypertens. 2009; 22:1199–204.CrossRefGoogle ScholarPubMed
Olson, JL. Renal disease caused by hypertension. In: Jennette, JC, Olson, JL, Silva, FG, D’Agati, VD, editors. Heptinstall’s Pathology of the Kidney, vol. 2, 7th ed. Philadelphia: Lippincott; 2014.Google Scholar
Intengan, HD, Schiffrin, EL. Structure and mechanical properties of resistance arteries in hypertension – role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000; 36:312–8.Google Scholar
Hill, GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008; 17:266–70.Google Scholar
Hill, G, Heudes, D, Bariety, J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int. 2003; 63:1027–36.Google Scholar
Hill, GS, Heudes, D, Jacquot, C, Gauthier, E, Bariety, J. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int. 2006; 69:823–31.Google Scholar
Tracy, RE, Parra, D, Eisaguirre, W, Torres Balanza, RA. Influence of arteriolar hyalinization on arterial intimal fibroplasia in the renal cortex of subjects in the United States, Peru, and Bolivia, applicable also to other populations. Am J Hypertens. 2002; 15:1064–73.Google Scholar
Hughson, MD, Johnson, K, Young, RJ, Hoy, WE, Bertram, JF. Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. American J Kidney Dis. 2002; 39:679–88.Google Scholar
Bohle, A, Ratschek, M. The compensated and the decompensated form of benign nephrosclerosis. Pathol Res Pract. 1982; 174:357–67.Google Scholar
Bohle, A, Wehrmann, M, Greschniok, A, Junghans, R. Renal morphology in essential hypertension: analysis of 1177 unselected cases. Kidney Int. 1998; 54(Suppl 67):S205–S6.Google Scholar
Larsen, CP, Beggs, ML, Saeed, M, et al. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease. Mod Pathol. 2015; 28:95–102.Google Scholar
Marcantoni, C, Ma, L-J, Federspiel, C, Fogo, A. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int. 2002; 62:172–80.Google Scholar
Gamble, C. The pathogenesis of hyaline arteriolosclerosis. Am J Pathol. 1986; 122:410.Google Scholar
Heptinstall, RH. Malignant hypertension: a study of fifty-one cases. J Pathol. 1953; 65: 423.Google Scholar
Jones, DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974; 31:303–13.Google ScholarPubMed
Gabbiani, G, Badonnel, MC, Rona, G. Cytoplasmic contractile apparatus in aortic endothelial cells of hypertensive rats. Lab Invest. 1975; 32:227–34.Google Scholar
Kaplan, C, Pasternack, B, Shah, H, Gallo, G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975; 80:227–34.Google Scholar
Martin, JE, Sheaff, MT. Renal ageing. J Pathol. 2007; 211:198–205.Google Scholar
Rule, A, Hatem, A, Cornell, LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010; 152:561–7.Google Scholar
John, GB, Cheng, CY, Kuro-o, M. Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis. 2011; 58:127–34.Google Scholar
Nakagawa, T, Kang, DH, Ohashi, R, et al. Tubulointerstitial disease: role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens. 2003; 12:233–41.Google Scholar
Thomas, SE, Anderson, S, Gordon, KL, et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol. 1998; 9:231–42.Google Scholar
Fine, DM, Garg, N, Haas, M, et al. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol. 2007; 2:1125–30.Google Scholar
Izzedine, H, Escudier, B, Lhomme, C, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center. Medicine. 2014; 93:333–9.Google Scholar
Nochy, D, Daugas, E, Droz, D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999; 10:507–18.Google Scholar
Ljutic, D, Kes, P. The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrol Dial Transplant. 2003; 18(Suppl 5):v28–30.Google Scholar
Perneger, TV, Whelton, PK, Klag, MJ. History of hypertension in patients treated for end-stage renal disease. J Hypertens. 1997; 15:451–6.Google Scholar
Bie, P, Wamberg, S, Kjolby, M. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand. 2004; 181:495–503.Google Scholar
Friso, S, Carvajal, CA, Fardella, CE, Olivieri, O. Epigenetics and arterial hypertension: the challenge of emerging evidence. Transl Res. 2015; 165:154–65.Google Scholar
Carthy, ER. Autonomic dysfunction in essential hypertension: a systematic review. Ann Med Surg. 2013; 3:2–7.Google Scholar
Grassi, G, Bertoli, S, Seravalle, G. Sympathetic nervous system: role in hypertension and in chronic kidney disease. Curr Opin Nephrol Hypertens. 2012; 21:46–51.Google Scholar
Grisk, O, Rettig, R. Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res. 2004; 61:238–46.CrossRefGoogle ScholarPubMed
Laffin, LJ, Bakris, GL. Hypertension and new treatment approaches targeting the sympathetic nervous system. Curr Opin Pharmacol. 2014; 21c:20–4.Google Scholar
Navar, LG. The role of the kidneys in hypertension. J Clin Hypertens (Greenwich). 2005; 7:542–9.Google Scholar
Marchesi, C, Paradis, P, Schiffrin, EL. Role of the renin–angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008; 29:367–74.Google Scholar
Vaidya, A, Brown, JM, Williams, JS. The renin–angiotensin–aldosterone system and calcium-regulatory hormones. J Hum Hypertens. 2015; 29:515–521.Google Scholar
Gkaliagkousi, E, Douma, S, Zamboulis, C, Ferro, A. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens. 2009; 27:2310–20.Google Scholar
Wilcox, CS. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension. 2012; 59:375–81.Google Scholar
Gonzalez, J, Valls, N, Brito, R, Rodrigo, R. Essential hypertension and oxidative stress: New insights. World J Cardiol. 2014; 6:353–66.Google Scholar
Burger, D, Schock, S, Thompson, CS, et al. Microparticles: biomarkers and beyond. Clin Sci. 2013; 124:423–41.Google Scholar
Helbing, T, Olivier, C, Bode, C, Moser, M, Diehl, P. Role of microparticles in endothelial dysfunction and arterial hypertension. World J Cardiol. 2014; 6:1135–9.Google Scholar
Feig, DI. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 2014; 26:176–85.Google Scholar
Johnson, RJ, Lanaspa, MA, Gabriela Sanchez-Lozada, L, Rodriguez-Iturbe, B. The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics. Am J Physiol Renal Physiol. 2015; 308:F167–78.Google Scholar
Pauletto, P, Rattazzi, M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant. 2006; 21:850–3.Google Scholar
Lifton, RP, Gharavi, AG, Geller, DS. Molecular mechanisms of human hypertension. Cell. 2001; 104:545–56.Google Scholar
Perera, G. Hypertensive vascular disease: description and natural history. J Chronic Dis. 1955; 1:33.CrossRefGoogle ScholarPubMed
Kannel, WB. Coronary atherosclerotic sequelae of hypertension. In: Oparil, S, Weber, MA, editors. Hypertension. Philadelphia: Elsevier-Saunders; 2005: 237–49.Google Scholar
Udani, S, Lazich, I, Bakris, GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 2011; 7:11–21.Google Scholar
Hsu, CY, McCulloch, CE, Darbinian, J, Go, AS, Iribarren, C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005; 165:923–8.Google Scholar
Gonzalez, R, Morales, E, Segura, J, Ruilope, LM, Praga, M. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant. 2010; 25:3266–72.Google Scholar
Hanratty, R, Chonchol, M, Havranek, EP, et al. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011; 6:2605–11.Google Scholar
Peralta, CA, Norris, KC, Li, S, et al. Blood pressure components and end-stage renal disease in persons with chronic kidney disease. Arch Intern Med. 2012; 172:41–7.Google Scholar
Martinez, F, Mansego, ML, Chaves, FJ, Redon, J. Genetic bases of urinary albumin excretion and related traits in hypertension. J Hypertens. 2010; 28:213–25.Google Scholar
Fabris, B, Bortoletto, M, Candido, R, et al. Genetic polymorphisms of the renin–angiotensin–aldosterone system and renal insufficiency in essential hypertension. J Hypertens. 2005; 23:309–16.Google Scholar
Genovese, G, Friedman, DJ, Ross, MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010; 329:841–5.Google Scholar
Reisin, E, Harris, RC, Rahman, M. Commentary on the 2014 BP Guidelines from the Panel Appointed to the Eighth Joint National Committee (JNC 8). J Am Soc Nephrol. 2014; 25:2419–24.Google Scholar
Mancia, G, Grassi, G. Management of essential hypertension. Br Med Bull. 2010; 94:189–99.Google Scholar
Gomez, SI, Urbandt, P, Beohar, N, Santana, O. Renal denervation: current status and future applications. Rev Cardiovasc Med. 2014; 15:351–7.Google Scholar
Weir, MR, Bakris, GL. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial? Am J Nephrol. 2010; 31:469–70.Google Scholar
Vikse, BE, Aasarod, K, Bostad, L, Iversen, BM. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant. 2003; 18:517–23.Google Scholar
Berglund, G, Andersson, O, Wilhelmsen, L. Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J. 1976; 2:554–6.Google Scholar
Danielson, M, Dammstrom, B. The prevalence of secondary and curable hypertension. Acta Med Scand. 1981; 209:451–5.Google Scholar
Omura, M, Saito, J, Yamaguchi, K, Kakuta, Y, Nishikawa, T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004; 27:193–202.Google Scholar
Sinclair, AM, Isles, CG, Brown, I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987; 147:1289–93.Google Scholar
Streeten, DH, Anderson, GH. Secondary hypertension. An overview of its causes and management. Drugs. 1992; 43:805–19.Google Scholar
Bech, K, Hilden, T. The frequency of secondary hypertension. Acta Med Scand. 1975; 197:65–9.Google Scholar
Gupta-Malhotra, M, Banker, A, Shete, S, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens. 2015; 28:73–80.Google Scholar
Lewin, A, Blaufox, MD, Castle, H, Entwisle, G, Langford, H. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med. 1985; 145:424–7.Google Scholar
Kitiyakara, C, Guzman, NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. 1998; 9:133–42.Google Scholar
Lip, GY, Beevers, M, Beevers, G. The failure of malignant hypertension to decline: a survey of 24 years’ experience in a multiracial population in England. J Hypertens. 1994; 12:1297–305.Google Scholar
Viera, AJ, Neutze, DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physic. 2010; 82:1471–8.Google Scholar
Piecha, G, Wiecek, A, Januszewicz, A. Epidemiology and optimal management in patients with renal artery stenosis. J Nephrol. 2012; 25:872–8.Google Scholar
Hirsch, AT, Haskal, ZJ, Hertzer, NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113:e463–654.Google Scholar
Hansen, KJ, Edwards, MS, Craven, TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002; 36:443–51.Google Scholar
Andersen, UB, Borglykke, A, Jorgensen, T. Prevalence of renal artery stenosis in subjects with moderate hypertension. A population-based study. Blood Pres. 2011; 20:140–4.Google ScholarPubMed
Holley, KE, Hunt, JC, Brown, AL Jr., Kincaid, OW, Sheps, SG. Renal artery stenosis. A clinical–pathologic study in normotensive and hypertensive patients. Am J Med. 1964; 37:14–22.Google Scholar
Sawicki, PT, Kaiser, S, Heinemann, L, Frenzel, H, Berger, M. Prevalence of renal artery stenosis in diabetes mellitus – an autopsy study. J Intern Med. 1991; 229:489–92.Google Scholar
Davis, RP, Pearce, JD, Craven, TE, et al. Atherosclerotic renovascular disease among hypertensive adults. J Vasc Surg. 2009; 50:564–70, 71 e1–3; discussion 71.Google Scholar
Benjamin, MM, Fazel, P, Filardo, G, Choi, JW, Stoler, RC. Prevalence of and risk factors of renal artery stenosis in patients with resistant hypertension. Am J Cardiol. 2014; 113:687–90.Google Scholar
Harding, MB, Smith, LR, Himmelstein, SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992; 2:1608–16.Google Scholar
Jean, WJ, al-Bitar, I, Zwicke, DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994; 32:8–10.Google Scholar
Rihal, CS, Textor, SC, Breen, JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clinic Proc. 2002; 77:309–16.Google Scholar
Weber-Mzell, D, Kotanko, P, Schumacher, M, Klein, W, Skrabal, F. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002; 23:1684–91.Google Scholar
Aqel, RA, Zoghbi, GJ, Baldwin, SA, et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens. 2003; 21:1157–62.Google Scholar
White, CJ, Olin, JW. Diagnosis and management of atherosclerotic renal artery stenosis: improving patient selection and outcomes. Nature Clin Pract Cardiovasc Med. 2009; 6:176–90.Google ScholarPubMed
Valentine, RJ, Myers, SI, Miller, GL, Lopez, MA, Clagett, GP. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg. 1993; 7:220–4.Google Scholar
Olin, JW, Melia, M, Young, JR, Graor, RA, Risius, B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990; 88:46N–51N.Google Scholar
Rimmer, JM, Gennari, FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993; 118:712–9.Google Scholar
Maxwell, MH, Bleifer, KH, Franklin, SS, Varady, PD. Cooperative study of renovascular hypertension. Demographic analysis of the study. J Am Med Assoc. 1972; 220:1195–204.Google Scholar
Mailloux, LU, Napolitano, B, Bellucci, AG, et al. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994; 24:622–9.Google Scholar
Textor, SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004; 15:1974–82.Google Scholar
Bookstein, JJ, Abrams, HL, Buenger, RE, et al. Radiologic aspects of renovascular hypertension. 3. Appraisal of arteriography. J Am Med Assoc 1972; 221:368–74.Google Scholar
Marcussen, N, Christensen, S, Petersen, JS, Shalmi, M. Atubular glomeruli, renal function and hypertrophic response in rats with chronic lithium nephropathy. Virch Archiv A, Pathol Anat Histopathol. 1991; 419:281–9.Google Scholar
Goldblatt, H, Lynch, J, Hanzal, RF, Summerville, WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934; 59:347–79.Google Scholar
De Bruyne, B, Manoharan, G, Pijls, NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006; 48:1851–5.Google Scholar
Schoenberg, SO, Bock, M, Kallinowski, F, Just, A. Correlation of hemodynamic impact and morphologic degree of renal artery stenosis in a canine model. J Am Soc Nephrol. 2000; 11:2190–8.Google Scholar
Rundback, JH, Sacks, D, Kent, KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interven Radiol. 2003; 14:S477–92.Google Scholar
Fatica, RA, Port, FK, Young, EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001; 37:1184–90.Google Scholar
Bonelli, FS, McKusick, MA, Textor, SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clinic Proc. 1995; 70:1041–52.Google Scholar
Garovic, VD, Textor, SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005; 112:1362–74.Google Scholar
Jenks, S, Yeoh, SE, Conway, BR. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Systematic Reviews. 2014; 12:CD002944.Google Scholar
Lawrie, GM, Morris, GC Jr., Glaeser, DH, DeBakey, ME. Renovascular reconstruction: factors affecting long-term prognosis in 919 patients followed up to 31 years. Am J Cardiol. 1989; 63:1085–92.Google Scholar
Baboolal, K, Evans, C, Moore, RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis. 1998; 31:971–7.Google Scholar
Losito, A, Errico, R, Santirosi, P, et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005; 20:1604–9.Google Scholar
Perdu, J, Boutouyrie, P, Bourgain, C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007; 21:393–400.Google Scholar
Blondin, D, Lanzman, R, Schellhammer, F, et al. Fibromuscular dysplasia in living renal donors: still a challenge to computed tomographic angiography. Eur J Radiol. 2010; 75:67–71.Google Scholar
Olin, JW, Froehlich, J, Gu, X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012; 125:3182–90.Google Scholar
Elliott, WJ. Renovascular hypertension: an update. J Clin Hypertens. 2008; 10:522–33.Google Scholar
Slovut, DP, Olin, JW. Fibromuscular dysplasia. New Engl J Med. 2004; 350:1862–71.Google Scholar
Nadasdy, T, Laszik, Z, Blick, KE, Johnson, DL, Silva, FG. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol. 1994; 25:22–8.Google Scholar
Garcia, CH, Krueger, K, Landing, BH, Wells, TR. Microdissection demonstration of the lesion of the endocrine kidney in children. Ped Pathol. 1986; 5:45–54.Google Scholar
Luscher, TF, Keller, HM, Imhof, HG, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron. 1986; 44(Suppl 1):109–14.Google Scholar
Olin, JW, Gornik, HL, Bacharach, JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014; 129:1048–78.Google Scholar
Southerland, AM, Meschia, JF, Worrall, BB. Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia. Curr Opin Neurol. 2013; 26:13–28.Google Scholar
Kim, ES, Olin, JW, Froehlich, JB, et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol. 2013; 62:2026–8.Google Scholar
Carmo, M, Bower, TC, Mozes, G, et al. Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg. 2005; 19:208–17.Google Scholar
Mousa, AY, Campbell, JE, Stone, PA, et al. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J Vasc Surg. 2012; 55:421–7.CrossRefGoogle Scholar
Trinquart, L, Mounier-Vehier, C, Sapoval, M, Gagnon, N, Plouin, PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010; 56:525–32.Google Scholar
Salyer, WR, Salyer, DC. The vascular lesions of neurofibromatosis. Angiology. 1974; 25:510–9.Google Scholar
Kayes, LM, Burke, W, Riccardi, VM, et al. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet. 1994; 54:424–36.Google Scholar
Kalff, V, Shapiro, B, Lloyd, R, et al. The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med. 1982; 142:2092–8.Google Scholar
Pillai, AK, Iqbal, SI, Liu, RW, Rachamreddy, N, Kalva, SP. Segmental arterial mediolysis. Cardiovasc Interven Radiol. 2014; 37:604–12.Google Scholar
Slavin, RE, Cafferty, L, Cartwright, J Jr. Segmental mediolytic arteritis. A clinicopathologic and ultrastructural study of two cases. Am J Surg Pathol. 1989; 13:558–68.Google Scholar
Soulen, MC, Cohen, DL, Itkin, M, Townsend, RR, Roberts, DA. Segmental arterial mediolysis: angioplasty of bilateral renal artery stenoses with 2-year imaging follow-up. J Vasc Interven Radiol. 2004; 15:763–7.CrossRefGoogle ScholarPubMed
Filippone, EJ, Foy, A, Galanis, T, et al. Segmental arterial mediolysis: report of 2 cases and review of the literature. Am J Kidney Dis. 2011; 58:981–7.Google Scholar
Tedla, FM, Brar, A, Browne, R, Brown, C. Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens. 2011; 2011:132405.Google Scholar
Peralta, CA, Weekley, CC, Li, Y, Shlipak, MG. Occult chronic kidney disease among persons with hypertension in the United States: data from the National Health and Nutrition Surveys 1988–1994 and 1999–2002. J Hypertens. 2013; 31:1196–202.Google Scholar
Jennette, JC, Falk, RJ, Bacon, PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthr Rheum. 2013; 65:1–11.CrossRefGoogle Scholar
Hall, S, Barr, W, Lie, JT, et al. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985; 64:89–99.Google Scholar
Watts, R, Al-Taiar, A, Mooney, J, Scott, D, Macgregor, A. The epidemiology of Takayasu arteritis in the UK. Rheumatology. 2009; 48:1008–11.Google Scholar
el-Reshaid, K, Varro, J, al-Duwairi, Q, Anim, JT. Takayasu’s arteritis in Kuwait. J Trop Med Hyg. 1995; 98:299–305.Google Scholar
Koide, K. Takayasu arteritis in Japan. Heart Vessels. 1992; 7(Suppl):48–54.Google Scholar
Reinhold-Keller, E, Herlyn, K, Wagner-Bastmeyer, R, Gross, WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthr Rheum. 2005; 53:93–9.Google Scholar
Chaudhry, MA, Latif, F. Takayasu’s arteritis and its role in causing renal artery stenosis. Am J Med Sci. 2013; 346:314–8.Google Scholar
Johnston, SL, Lock, RJ, Gompels, MM. Takayasu arteritis: a review. J Clin Pathol. 2002; 55:481–6.Google Scholar
Terao, C, Yoshifuji, H, Mimori, T. Recent advances in Takayasu arteritis. Int J Rheum Dis. 2014; 17:238–47.Google Scholar
Saruhan-Direskeneli, G, Hughes, T, Aksu, K, et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013; 93:298–305.Google Scholar
Terao, C, Yoshifuji, H, Kimura, A, et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am J Hum Genet. 2013; 93:289–97.Google Scholar
Terao, C, Yoshifuji, H, Ohmura, K, et al. Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Rheumatology. 2013; 52:1769–74.Google Scholar
Lv, N, Wang, Z, Dang, A, et al. HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in Chinese Han population. Hum Immunol. 2015; 76:241–4.Google Scholar
Aggarwal, A, Chag, M, Sinha, N, Naik, S. Takayasu’s arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol. 1996; 55:49–55.Google Scholar
Kumar Chauhan, S, Kumar Tripathy, N, Sinha, N, Singh, M, Nityanand, S. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu’s arteritis. Clin Exp Immunol. 2004; 138:547–53.Google Scholar
Soto, ME, Del Carmen Avila-Casado, M, Huesca-Gomez, C, et al. Detection of IS6110 and HupB gene sequences of Mycobacterium tuberculosis and bovis in the aortic tissue of patients with Takayasu’s arteritis. BMC Infect Dis. 2012; 12:194.Google Scholar
Arnaud, L, Cambau, E, Brocheriou, I, et al. Absence of Mycobacterium tuberculosis in arterial lesions from patients with Takayasu’s arteritis. J Rheumatol. 2009; 36:1682–5.Google Scholar
Subramanyan, R, Joy, J, Balakrishnan, KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation. 1989; 80:429–37.Google Scholar
Park, MC, Lee, SW, Park, YB, Chung, NS, Lee, SK. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005; 34:284–92.Google Scholar
Schmidt, J, Kermani, TA, Bacani, AK, et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clinic Proc. 2013; 88:822–30.Google Scholar
Smeeth, L, Cook, C, Hall, AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheumat Dis. 2006; 65:1093–8.Google Scholar
Gran, JT, Myklebust, G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94. J Rheumatol. 1997; 24:1739–43.Google Scholar
Dunstan, E, Lester, SL, Rischmueller, M, et al. Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J. 2014; 44:32–9.Google Scholar
Boesen, P, Sorensen, SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982–1985. Arthrit Rheum. 1987; 30:294–9.Google Scholar
Franzen, P, Sutinen, S, von Knorring, J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988. J Rheumatol. 1992; 19:273–6.Google Scholar
Gonzalez-Gay, MA, Garcia-Porrua, C, Rivas, MJ, Rodriguez-Ledo, P, Llorca, J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis. 2001; 60:367–71.Google Scholar
Bas-Lando, M, Breuer, GS, Berkun, Y, et al. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol. 2007; 25:S15–7.Google Scholar
Gonzalez-Gay, MA, Pina, T. Giant cell arteritis and polymyalgia rheumatica: an update. Curr Rheumatol Rep. 2015; 17:6.Google Scholar
Klein, RG, Hunder, GG, Stanson, AW, Sheps, SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975; 83:806–12.Google Scholar
Prieto-Gonzalez, S, Arguis, P, Garcia-Martinez, A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheumat Dis. 2012; 71:1170–6.Google Scholar
Lie, JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthrit Rheum. 1990; 33:1074–87.Google Scholar
Carmona, FD, Gonzalez-Gay, MA, Martin, J. Genetic component of giant cell arteritis. Rheumatology. 2014; 53:6–18.Google Scholar
Elling, P, Olsson, AT, Elling, H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996; 23:112–9.Google Scholar
Duhaut, P, Bosshard, S, Calvet, A, et al. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l’Arterite a Cellules Geantes. J Rheumatol. 1999; 26:361–9.Google Scholar
Weyand, CM, Goronzy, JJ. Immune mechanisms in medium and large-vessel vasculitis. Nature Rev Rheumatol. 2013; 9:731–40.Google Scholar
Huston, KA, Hunder, GG, Lie, JT, Kennedy, RH, Elveback, LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978; 88:162–7.Google Scholar
Baslund, B, Helleberg, M, Faurschou, M, Obel, N. Mortality in patients with giant cell arteritis. Rheumatology. 2015; 54:139–43.Google Scholar
Ninan, J, Nguyen, AM, Cole, A, et al. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study. J Rheumatol. 2011; 38:2215–7.Google Scholar
Mohammad, AJ, Nilsson, JA, Jacobsson, LT, Merkel, PA, Turesson, C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheumat Dis. 2015; 74:993–7.Google Scholar
Gran, JT, Myklebust, G, Wilsgaard, T, Jacobsen, BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology. 2001; 40:1238–42.Google Scholar
Matteson, EL, Gold, KN, Bloch, DA, Hunder, GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996; 100:193–6.Google Scholar
Rajala, SA, Ahvenainen, JE, Mattila, KJ, Saarni, MI. Incidence and survival rate in cases of biopsy-proven temporal arteritis. Scand J Rheumatol. 1993; 22:289–91.CrossRefGoogle ScholarPubMed
Pagnoux, C, Seror, R, Henegar, C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthrit Rheum. 2010; 62:616–26.Google Scholar
Lane, SE, Scott, DG, Heaton, A, Watts, RA. Primary renal vasculitis in Norfolk – increasing incidence or increasing recognition? Nephrol Dialy Transplant. 2000; 15:23–7.Google Scholar
Mohammad, AJ, Jacobsson, LT, Westman, KW, Sturfelt, G, Segelmark, M. Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa. Rheumatology. 2009; 48:1560–5.Google Scholar
Watts, RA, Gonzalez-Gay, MA, Lane, SE, et al. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheumat Dis. 2001; 60:170–2.CrossRefGoogle ScholarPubMed
Hernandez-Rodriguez, J, Alba, MA, Prieto-Gonzalez, S, Cid, MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014; 48–49:84–9.Google Scholar
Zhou, Q, Yang, D, Ombrello, AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. New Engl J Med. 2014; 370:911–20.Google Scholar
Gayraud, M, Guillevin, L, le Toumelin, P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome: analysis of four prospective trials including 278 patients. Arthrit Rheum. 2001; 44:666–75.Google Scholar
Bourgarit, A, Le Toumelin, P, Pagnoux, C, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine. 2005; 84:323–30.Google Scholar
Dimitriades, VR, Brown, AG, Gedalia, A. Kawasaki disease: pathophysiology, clinical manifestations, and management. Curr Rheumatol Rep. 2014; 16:423.Google Scholar
Holman, RC, Belay, ED, Christensen, KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Ped Infect Dis J. 2010; 29:483–8.Google Scholar
Callinan, LS, Holman, RC, Vugia, DJ, Schonberger, LB, Belay, ED. Kawasaki disease hospitalization rate among children younger than 5 years in California, 2003–2010. Ped Infect Dis J. 2014; 33:781–3.Google Scholar
Nakamura, Y, Yashiro, M, Uehara, R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol. 2012; 22:216–21.Google Scholar
Rowley, AH, Shulman, ST. Kawasaki syndrome. Clin Microbiol Rev. 1998; 11:405–14.Google Scholar
Council on Cardiovascular Disease in the Young Committee on Rheumatic Fever Endocarditis, Kawasaki Disease American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation. 2001; 103:335–6.Google Scholar
Baer, AZ, Rubin, LG, Shapiro, CA, et al. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Ped Adolesc Med. 2006; 160:686–90.Google Scholar
Dominguez, SR, Anderson, MS, El-Adawy, M, Glode, MP. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease. Ped Infect Dis J. 2012; 31:1217–20.Google Scholar
Printz, BF, Sleeper, LA, Newburger, JW, et al. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011; 57:86–92.Google Scholar
Suzuki, A, Kamiya, T, Kuwahara, N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Ped Cardiol. 1986; 7:3–9.Google Scholar
Amano, S, Hazama, F, Hamashima, Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jap Circul J. 1979; 43:633–43.Google Scholar
Amano, S, Hazama, F, Hamashima, Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jap Circul J. 1979; 43:741–8.Google Scholar
Amano, S, Hazama, F, Kubagawa, H, et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 1980; 30:681–94.Google Scholar
Naoe, S, Takahashi, K, Masuda, H, Tanaka, N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn. 1991; 41:785–97.Google Scholar
Takahashi, K, Oharaseki, T, Yokouchi, Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol. 2011; 164(Suppl 1):20–2.Google Scholar
Onouchi, Y. Genetics of Kawasaki disease: what we know and don’t know. Circul J. 2012; 76:1581–6.Google Scholar
Uehara, R, Yashiro, M, Nakamura, Y, Yanagawa, H. Parents with a history of Kawasaki disease whose child also had the same disease. Ped Int. 2011; 53:511–4.Google Scholar
Uehara, R, Yashiro, M, Nakamura, Y, Yanagawa, H. Kawasaki disease in parents and children. Acta Paediatr. 2003; 92:694–7.Google Scholar
Fujita, Y, Nakamura, Y, Sakata, K, et al. Kawasaki disease in families. Pediatrics. 1989; 84:666–9.Google Scholar
Burns, JC, Glode, MP. Kawasaki syndrome. Lancet. 2004; 364:533–44.Google Scholar
Newburger, JW, Takahashi, M, Burns, JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. New Engl J Med. 1986; 315:341–7.Google Scholar
Daniels, LB, Gordon, JB, Burns, JC. Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol. 2012; 27:572–7.Google Scholar
Singhal, R, Brimble, KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118:397–407.Google Scholar
Llach, F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985; 28:429–39.Google Scholar
Harris, RC, Ismail, N. Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis. 1994; 23:477–97.Google Scholar
Wagoner, RD, Stanson, AW, Holley, KE, Winter, CS. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int. 1983; 23:368–74.Google Scholar
Barbano, B, Gigante, A, Amoroso, A, Cianci, R. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013; 39:469–76.Google Scholar
Asghar, M, Ahmed, K, Shah, SS, et al. Renal vein thrombosis. Eur J Vasc Endovasc Surg. 2007; 34:217–23.Google Scholar
Rostoker, G, Durand-Zaleski, I, Petit-Phar, M, et al. Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin. Nephron. 1995; 69:20–8.Google Scholar
Wu, CH, Ko, SF, Lee, CH, et al. Successful outpatient treatment of renal vein thrombosis by low-molecular weight heparins in 3 patients with nephrotic syndrome. Clin Nephrol. 2006; 65:433–40.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×